<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101313252</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34584</journal-id>
<journal-id journal-id-type="nlm-ta">J Vis Exp</journal-id>
<journal-id journal-id-type="iso-abbrev">J Vis Exp</journal-id>
<journal-title-group>
<journal-title>Journal of visualized experiments : JoVE</journal-title>
</journal-title-group>
<issn pub-type="epub">1940-087X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31498321</article-id>
<article-id pub-id-type="pmc">7418855</article-id>
<article-id pub-id-type="doi">10.3791/59658</article-id>
<article-id pub-id-type="manuscript">NIHMS1602847</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>In Vivo Functional Study of Disease-Associated Rare Human Variants using Drosophila</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Harnish</surname>
<given-names>J. Michael</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deal</surname>
<given-names>Samantha L.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<collab>Undiagnosed Diseases Network</collab>
<xref ref-type="author-notes" rid="FN1">%</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chao</surname>
<given-names>Hsiao-Tuan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wangler</surname>
<given-names>Michael F.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>Shinya</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA</aff>
<aff id="A2"><label>2</label>Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, Section of Neurology and Developmental Neuroscience, Baylor College of Medicine, Houston, TX, USA</aff>
<aff id="A4"><label>4</label>Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX, USA</aff>
<aff id="A5"><label>5</label>Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA</aff>
<author-notes>
<fn id="FN1">
<label>%</label>
<p id="P1">A list of members of the Undiagnosed Diseases Network is provided in <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 1</xref>.</p>
</fn>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p id="P2">These authors contributed equally.</p>
</fn>
<corresp id="CR1"><bold>Corresponding Author:</bold> Shinya Yamamoto (<email>yamamoto@bcm.edu</email>) Tel: +1-832-824-8119</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<day>20</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>8</month>
<year>2020</year>
</pub-date>
<issue>150</issue>
<elocation-id>10.3791/59658</elocation-id>
<abstract id="ABS1">
<p id="P3">Advances in sequencing technology have made whole-genome and whole-exome datasets more accessible for both clinical diagnosis and cutting-edge human genetics research. Although a number of in silico algorithms have been developed to predict the pathogenicity of variants identified in these datasets, functional studies are critical to determining how specific genomic variants affect protein function, especially for missense variants. In the Undiagnosed Diseases Network (UDN) and other rare disease research consortia, model organisms (MO) including <italic>Drosophila, C. elegans,</italic> zebrafish, and mice are actively used to assess the function of putative human disease-causing variants. This protocol describes a method for the functional assessment of rare human variants used in the Model Organisms Screening Center <italic>Drosophila</italic> Core of the UDN. The workflow begins with gathering human and MO information from multiple public databases, using the MARRVEL web resource to assess whether the variant is likely to contribute to a patient’s condition as well as design effective experiments based on available knowledge and resources. Next, genetic tools (e.g., T2A-GAL4 and UAS-human cDNA lines) are generated to assess the functions of variants of interest in <italic>Drosophila.</italic> Upon development of these reagents, two-pronged functional assays based on rescue and overexpression experiments can be performed to assess variant function. In the rescue branch, the endogenous fly genes are “humanized” by replacing the orthologous <italic>Drosophila</italic> gene with reference or variant human transgenes. In the overexpression branch, the reference and variant human proteins are exogenously driven in a variety of tissues. In both cases, any scorable phenotype (e.g., lethality, eye morphology, electrophysiology) can be used as a read-out, irrespective of the disease of interest. Differences observed between reference and variant alleles suggest a variant-specific effect, and thus likely pathogenicity. This protocol allows rapid, in vivo assessments of putative human disease-causing variants of genes with known and unknown functions.</p>
</abstract>
<abstract abstract-type="summary" id="ABS2">
<title>SUMMARY:</title>
<p id="P4">The goal of this protocol is to outline the design and performance of in vivo experiments in <italic>Drosophila melanogaster</italic> to assess the functional consequences of rare gene variants associated with human diseases.</p>
</abstract>
<kwd-group>
<kwd>human genetics and genomics</kwd>
<kwd>Mendelian diseases</kwd>
<kwd>rare and undiagnosed diseases</kwd>
<kwd>Undiagnosed Diseases Network</kwd>
<kwd>
<italic>Drosophila melanogaster</italic>
</kwd>
<kwd>variant of unknown significance</kwd>
<kwd>VUS</kwd>
<kwd>gene of uncertain significance</kwd>
<kwd>GUS</kwd>
<kwd>functional genomics</kwd>
<kwd>transgenic flies</kwd>
<kwd>UAS/GAL4 system</kwd>
<kwd>T2A-GAL4</kwd>
<kwd>electroretinogram</kwd>
<kwd>ERG</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>